Kurome Therapeutics
Shyam Masrani as the Principal at Medicxi, a Member of the Board at Monopteros. He is also the Founding Partner at Shyden Biotechnology, Cleavr Therapeutics.
This person is not in the org chart
This person is not in any offices
Kurome Therapeutics
Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.